Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma
Fang, Shen-Cun, Zhang, Hai-Tao, Zhang, Ying-Ming, Xie, Wei-PingVolume:
Volume 10
Language:
english
Journal:
OncoTargets and Therapy
DOI:
10.2147/OTT.S126613
Date:
January, 2017
File:
PDF, 4.29 MB
english, 2017